Navigation Links
USAID Provides Malaria Assistance to Zimbabwe
Date:2/6/2009

WASHINGTON, Feb. 6 /PRNewswire-USNewswire/ -- The U.S. Agency for International Development (USAID) continues to provide assistance to the people of Zimbabwe, who are in the midst of an expanding humanitarian crisis. An ailing economy, food shortages and the cholera epidemic have left the people of Zimbabwe in danger of other health risks.

USAID, through the President's Malaria Initiative, is supporting emergency Indoor Residual Spraying (IRS) to shore up gaps in the country's usually strong spraying efforts. While the country retains adequate stocks of malaria drugs, less than half of the usual level of indoor mosquito spraying has occurred. The program will reach 20 districts that would have otherwise gone without this integral malaria protection mechanism. The Ministry of Health in Zimbabwe has stated that this accelerated program will avert 4 million cases and will save 3,000 to 4,000 lives.

The timing of this intervention is vitally important as it will cover a large portion of the population just in time for the season of highest malaria transmittance. Malaria cases in Zimbabwe begin to rise in February and peak in April and May.

Indoor Residual Spraying shortens the lifetime of mosquitoes that carry the malaria parasite. When a mosquito lands in a home that has been sprayed, the mosquito is killed or its life is shortened so that it cannot pass parasites from one person to another.

USAID provided emergency funding of $200,000 along with the UK's Department for International Development's (DFID) providing 200,000 pounds Sterling to enable the National Malaria Control Program to launch a two-month "Accelerated IRS" program in February and March, before peak transmission in April and May. The two responded immediately, procuring equipment, mobilizing teams and transport, and disbursing equipment for approximately 821 spray operators.

For
'/>"/>

SOURCE U.S. Agency for International Development
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. The Female Health Company Receives USAID DELIVER PROJECT Order for 5 Million Units
2. Ethics Group Asks USAID Inspector General to Investigate Legality of Grants to Soros Groups
3. CuraGen Provides Update on Velafermin, Belinostat and CR011-vcMMAE Clinical Development Programs
4. Access Pharmaceuticals Provides Update on Clinical Development Plan of ProLindac
5. Study Shows Combination Therapy Incorporating AVODART(R) and Tamsulosin Provides Continuous Symptom Improvement Over 2 Years
6. Raptor Pharmaceuticals Provides Update of Product Programs
7. Monogram Provides Update on Trofile(TM) Co-Receptor Tropism Assay
8. Arbios Provides Clinical Strategy for SEPET(TM) Pivotal Trial
9. Innocoll Provides a Progress Update on its Clinical Development Programs and Specialty Pharmaceutical Operations
10. Genaera Corporation Provides Highlights of Positive Phase 1 Trodusquemine (MSI-1436) Data from the North American Association for the Study of Obesity Annual Meeting
11. Favrille Provides Update on Timing of Analysis from Pivotal Phase 3 Clinical Trial; Reports Third Quarter 2007 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2015)... , July 29, 2015  Cryoport, Inc. ... "Company"), the leading provider of advanced cryogenic ... serving markets including immunotherapies, stem cells, cell ... health, and reproductive medicine, announced today that ... common stock and warrants (the "Units") under a registered ...
(Date:7/29/2015)... Colo., July 29, 2015 Heska Corporation ... a provider of advanced veterinary diagnostic and other specialty ... quarter ended June 30, 2015. Second Quarter ... Operations was up nearly 100% to $1.829 million, from $917 ... to $10.1 million, from $7.8 million. , Core Companion ...
(Date:7/29/2015)... , July 27, 2015 Research and ... of the "Global Neurostimulation Devices Market 2015" ... analysts forecast the global neurostimulation devices market to ... period 2014-2019. The report, Global Neurostimulation ... an in-depth market analysis with inputs from industry ...
Breaking Medicine Technology:Cryoport Completes $6.8 Million Equity Capital Raise 2Cryoport Completes $6.8 Million Equity Capital Raise 3Heska Reports Financial Results for the Second Quarter of 2015 2Heska Reports Financial Results for the Second Quarter of 2015 3Heska Reports Financial Results for the Second Quarter of 2015 4Heska Reports Financial Results for the Second Quarter of 2015 5Heska Reports Financial Results for the Second Quarter of 2015 6Heska Reports Financial Results for the Second Quarter of 2015 7Heska Reports Financial Results for the Second Quarter of 2015 8Global Neurostimulation Devices Market 2015-2019 2
... NEW YORK, Aug. 14 Immtech Pharmaceuticals,Inc. (Amex: ... paper published in Nucleic,Acids Research by a group ... ability of furamidine to inhibit a key enzyme ... Furamidine is the active metabolite (DB75),of Immtech,s proprietary, ...
... Scheduled Start of Phase 3 Clinical Trial, BELTSVILLE, ... has reported a second quarter 2007 loss from continuing,operations ... to a loss from,continuing operations of $699,000, or 5 ... from discontinued operations in the second quarter,of 2007 was ...
Cached Medicine Technology:Furamidine Found to Inhibit a Key Enzyme Involved in Cancer Cell DNA Repair Mechanisms 2Furamidine Found to Inhibit a Key Enzyme Involved in Cancer Cell DNA Repair Mechanisms 3Spherix Reports Second Quarter Earnings 2
(Date:7/29/2015)... Plains, NJ (PRWEB) , ... July 29, 2015 , ... ... , Dr. Andrzej Klos, a board-certified pediatrician for nearly 38 years, is motivated each ... work, dedication and commitment to his profession shine alongside his many awards and accolades, ...
(Date:7/29/2015)... ... July 29, 2015 , ... According to the The ... legal, and are exposed to advertisements, for medicinal use are more likely to abuse ... where the use of marijuana is considered beneficial are more apt to use the ...
(Date:7/29/2015)... (PRWEB) , ... July 29, 2015 , ... Angelo’s FabriClean, ... its new service: water damage restoration of carpets and rugs. The company will now ... as for commercial clients. , An overflowing overhead tank, rain leaking through an ...
(Date:7/29/2015)... Park, Pa. (PRWEB) , ... July 29, 2015 ... ... education services for autism. Parents, educators and service providers of children living with ... practices to better serve the growing demographic. , The National Autism Conference ...
(Date:7/29/2015)... ... July 29, 2015 , ... Topical BioMedics, Inc., ... Pain Relief and Healing Cream designated as the nonprofit’s natural pain reliever of ... addressing Line of Duty Deaths (LODD) and the high rate of pain and ...
Breaking Medicine News(10 mins):Health News:NJ Top Docs Presents, Dr. Andrzej Klos of Carepoint Health Pediatrics! 2Health News:NJ Top Docs Presents, Dr. Andrzej Klos of Carepoint Health Pediatrics! 3Health News:New Study Reveals Teens Use Marijuana More in States Where Marijuana Is Legalized 2Health News:New Study Reveals Teens Use Marijuana More in States Where Marijuana Is Legalized 3Health News:Angelo’s FabriClean Now Offers Water Damage Restoration For Residential and Commercial Accounts 2Health News:Penn State Conference to Address Instruction, Success for Children with Autism 2Health News:Topical BioMedics Partners with 555 Fitness: Topricin® Designated as the Nonprofit’s Natural Pain Reliever of Choice 2Health News:Topical BioMedics Partners with 555 Fitness: Topricin® Designated as the Nonprofit’s Natural Pain Reliever of Choice 3Health News:Topical BioMedics Partners with 555 Fitness: Topricin® Designated as the Nonprofit’s Natural Pain Reliever of Choice 4Health News:Topical BioMedics Partners with 555 Fitness: Topricin® Designated as the Nonprofit’s Natural Pain Reliever of Choice 5Health News:Topical BioMedics Partners with 555 Fitness: Topricin® Designated as the Nonprofit’s Natural Pain Reliever of Choice 6
... Cholesterol-lowering meds linked to less tumor inflammation, research ... Cholesterol-lowering statins significantly reduce prostate tumor inflammation, which ... new study findings suggest. , Duke University Medical ... before prostate cancer surgery was associated with a ...
... Consideration of patient,s needs and beliefs helps preserve relationship, ... When a patient asks for a treatment that a ... very, very carefully. , Television advertising of prescription medicines ... inappropriate for them. And new research finds that taking ...
... ... ... ... ...
... ... ... ... ...
... COLUMBIA, Mo. Thousands of men, women and ... the U.S. Department of Justice. Traditionally, therapy for ... trauma and pain. In contrast, a University of ... survivors through highlighting their resilience, resourcefulness, and ability ...
... ... ... , ... , , , ...
Cached Medicine News:Health News:Statins May Benefit Prostate Cancer Patients 2Health News: Doctors Have Many Ways to Say 'No' 2Health News: Doctors Have Many Ways to Say 'No' 3Health News:Los Angeles Jewish Home Adds Short-Term Rehabilitative Care to Family of Services 2Health News:Los Angeles Jewish Home Adds Short-Term Rehabilitative Care to Family of Services 3Health News:Los Angeles Jewish Home Adds Short-Term Rehabilitative Care to Family of Services 4Health News:Heska Announces Q4 and Annual 2009 Results 2Health News:Heska Announces Q4 and Annual 2009 Results 3Health News:Heska Announces Q4 and Annual 2009 Results 4Health News:Heska Announces Q4 and Annual 2009 Results 5Health News:Heska Announces Q4 and Annual 2009 Results 6Health News:Heska Announces Q4 and Annual 2009 Results 7Health News:Heska Announces Q4 and Annual 2009 Results 8Health News:Husbands' hostile, anti-social behaviors increase wives' symptoms of depression, researchers find 2Health News:Federal Government Premium Review Ignores Real Factors Driving Healthcare Costs 2Health News:Federal Government Premium Review Ignores Real Factors Driving Healthcare Costs 3Health News:Federal Government Premium Review Ignores Real Factors Driving Healthcare Costs 4
For the quantitative determination of direct bilirubin in human serum. Linearity: 20 mg/dl...
For the quantitative determination of direct & total bilirubin in serum. Modified Malloy-Evelyn Diazotization Method. Endpoint Reaction Product measured at 540 nm. Linearity: 20 mg/dl...
... first microplate spectrophotometer designed specifically to run ... week. With rugged hardware, proven optical performance ... barrier of traditional spectrophotometry to obtain results ... easily read up to eight, 1 cm ...
... 1100RS Spectrophotometers are simple, ... for use in many ... educational, clinical, industrial and ... COD vial holders, Windows ...
Medicine Products: